Predicting the Introduction and Transmission of Rift Valley Fever Virus in the United States by Golnar, Andrew John
  
PREDICTING THE INTRODUCTION AND TRANSMISSION OF RIFT VALLEY 
FEVER VIRUS IN THE UNITED STATES 
 
 
A Thesis 
by 
ANDREW JOHN GOLNAR 
 
 
Submitted to the Office of Graduate and Professional Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of 
 
MASTER OF SCIENCE 
 
 
Chair of Committee,  Gabriel Hamer 
Committee Members, Robert Coulson 
 Bret Collier 
Head of Department, David Ragsdale 
 
December 2014 
 
Major Subject: Entomology 
 
Copyright 2014 Andrew John Golnar
  
 
ii 
ABSTRACT 
 
 Rift Valley fever virus (RVFV) is a mosquito-borne virus in the family 
Bunyaviridae that has spread throughout continental Africa to Madagascar and the 
Arabian Peninsula.  The establishment of RVFV in North America would have serious 
consequences for human and animal health in addition to a significant economic impact 
on the livestock industry.  Specific objectives of this thesis are to identify high-risk 
regions involved in RVFV importation to the U.S., evaluate pathways of introduction, 
and theoretically quantify the relative importance of local vectors and vertebrate hosts to 
RVFV transmission should the virus reach the U.S. 
To estimate the relative risk of RVFV introduction to the U.S., the number of 
infectious mosquitoes arriving in the U.S. was quantified for five pathways: infected 
mosquitoes arriving by airplane, infected mosquitoes arriving by boat, infected 
mosquitoes arriving through tire trade, infected humans arriving by flight, and the trade 
of infected mammals.  Results suggest that mosquito transport by airplane, mosquito 
transport by ship, and human travel are important pathways for RVFV introduction to 
the U.S.  New York, Houston, Washington D.C., and Atlanta are high-risk regions for 
RVFV introduction in the U.S.  Further, Saudi Arabia, South Africa, Nigeria, Egypt, 
Senegal, Ethiopia, Yemen and Angola are identified as regions at-risk for importing 
RVFV to the U.S.  
 Published and unpublished data on RVFV vector competence, vertebrate host 
competence, and mosquito feeding patterns from the United States were combined to 
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quantitatively implicate mosquito vectors and vertebrate hosts that may be important to 
RVFV transmission in the United States.  A viremia-vector competence relationship 
based on published mosquito transmission studies was used to calculate a vertebrate host 
competence index which was then combined with mosquito blood feeding patterns to 
approximate the relative contribution of a mosquito or vertebrate host to RVFV 
transmission.  Results implicate several Aedes spp. mosquitoes and vertebrates in the 
order Artiodactyla as important hosts for RVFV transmission in the U.S.  Moreover, this 
study identifies critical gaps in knowledge necessary to comprehensively evaluate the 
different contributions of mosquitoes and vertebrates to potential RVFV transmission in 
the U.S.  
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Globalization and the movement of people and goods worldwide is reshaping 
global ecosystems and facilitating the spread of pathogens (Tatem and Tatem 2006, 
Hatcher et al. 2012).  With the discovery of 100 new viral diseases in the past 30 years, 
pathogen dispersal is moving to the forefront of the public health arena (Daszak et al. 
2000, Gubler 2002, Apperson et al. 2004).  Biological invasions are associated with a 
variety of adverse affects and are often irreversible once established (Simberloff 2005). 
For this reason, it is important to take proactive approaches to prevent pathogen 
introduction.  The objective of this thesis is to quantitatively evaluate important 
transmission hosts and routes of introduction to the United States for Rift Valley fever 
virus (RVFV), a mosquito-borne virus (arbovirus) recognized as a potential threat to the 
United States (U.S.) due to its effect on human and animal health and demonstrated 
ability to spread geographically.   
The invasion of the new world by West Nile virus (WNV) demonstrates that 
developed nations such as the United States (U.S.) are vulnerable to zoonotic diseases.  
Once WNV was introduced to New York in 1999, it quickly spread through the 
contiguous U.S. resulting in more than 30,000 cases of human illness and over 1,500 
deaths (CDC 2014b).  During the initial epidemics of WNV in the U.S. in 2002 and 
2003, many mosquito control programs did not have a strong focus on Culex spp. 
mosquitoes.  As knowledge of the WNV transmission system increased, vector control 
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has improved by targeting Culex species to reduce human exposure events.  The delay of 
Culex spp. vector control might have allowed more human WNV disease and may have 
contributed to the rapid spread of the virus across the U.S. highlighting the importance 
of a priori response strategies for potential viral threats.  
Rift Valley fever virus (RVFV) is an emerging infectious disease in Africa and 
the Middle East.  If introduced to North America, RVFV is capable of serious health and 
socioeconomic consequences potentially incapacitating large numbers of humans, 
susceptible farm animals, and instigating heavy restrictions on livestock trade (Weaver 
and Reisen 2010, Hartley et al. 2011).  Although transmission of the virus can occur 
through aerosol inhalation or direct tissue-tissue contact by handling of infected 
organisms, an enzootic cycle between mosquito vectors and domestic or wild animals 
has been repeatedly proposed as a main mechanism of transmission (Meegan and Bailey 
1988).  
RVFV was first reported in Kenya in 1931.  It spread to Egypt in 1977 and was 
detected on the Arabian Peninsula in 2000 (Meegan 1979, Fagbo 2002). As the 
frequency of international travel and trade rises the importation of RVFV infected hosts 
is likely to increase.  It remains to be determined which regions in the U.S. are most at 
risk for RVFV introduction ultimately hindering the development of appropriate 
introduction prevention and response strategies (Hartley et al. 2011).  
The emergence of arthropod-borne viruses (arboviruses) through geographic 
expansion is facilitated when amplification hosts include wild or domestic animals, as 
demonstrated by West Nile virus (WNV), Japanese encephalitis, and epizootic 
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hemorrhagic disease (Weaver 2005, Weaver and Reisen 2010). Even though RVFV is 
identified as an emerging infectious disease threat and is classified as a “Category A 
select agent” by both the Centers for Disease Control and Prevention and the U.S. 
Department of Agriculture, gaps in data are preventing a proper evaluation of the 
different roles vectors and vertebrate hosts that potentially may play in RVFV 
transmission in the U.S. (Hartley et al. 2011, Rolin et al. 2013).  Although significant 
progress is being made with the development of animal vaccines for RVFV, vaccine 
programs targeting domestic animals might not be sufficient to break the transmission 
cycle of RVFV in the U.S. if wild animals are responsible for maintaining and 
amplifying the virus (Kakani et al. 2010, Hartley et al. 2011, Rolin et al. 2013).   
In anticipation of continued pathogen emergence, proactive management plans 
and intervention strategies need detailed information on the regions in the U.S. at risk for 
RVFV introduction, the key pathways likely to be involved in RVFV introduction, and 
an understanding of the local vector and host populations in high risk regions. The 
invasion process is often difficult to foresee, as it is a complex of demographic, 
evolutionary, and environmental factors.  A number of reviews discuss potential 
vertebrate hosts, disease vectors, and environments potentially conducive to RVFV 
transmission in the U.S., but none have quantitatively evaluated the relative risk of 
different introduction pathways into the U.S. or quantitatively evaluated the theoretical 
importance of different mosquito species and vertebrate hosts to RVFV transmission and 
amplification in the U.S. (Kasari et al. 2008, Hartley et al. 2011, Barker et al. 2013, 
Rolin et al. 2013, Golnar et al. 2014).  
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CHAPTER II 
QUANTIFYING PATHWAYS OF RIFT VALLEY FEVER VIRUS INTRODUCTION 
TO THE UNITED STATES 
 
Introduction 
Globalization and the movement of people and goods worldwide is reshaping 
global ecosystems and facilitating the spread of pathogens. (Tatem and Tatem 2006, 
Hatcher et al. 2012).  The invasion of West Nile virus (WNV) to the United States (U.S.) 
in 1999, outbreak of monkeypox virus in the Midwest in 2003, and spread of 
chikungunya to the Caribbean in 2013 underscore the continual threat of pathogen 
dispersal in even in developed countries such as the U.S. (CDC 2003, Kilpatrick 2011, 
Powers 2014). 
Importation of invasive mosquito species has resulted in dramatic 
epidemiological consequences.  The spread of Aedes aegypti to the new world aboard 
slave trade ships arriving from Africa in the early fifteenth century is an infamous 
example of mosquito importation.  Vector arrival enhanced Yellow Fever virus 
transmission, which significantly increased mortality in urban areas (Lounibos 2002). 
The introduction of the more aggressive and anthropophilic malaria vector, Anopheles 
gambiae, to Brazil in 1930 is an equally notorious event which increased malaria 
transmission up to 25% (Lounibos 2002).  More contemporary examples of mosquito 
import include Aedes albopictus, the Asian tiger mosquito, which has spread to the U.S. 
and 28 other countries through the shipment of car tires (Craven et al. 1988, Benedict et 
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al. 2007).  Similarly, Aedes japonicus japonicus arrived to the U.S. through tire imports 
in 1998 and quickly established throughout the U.S. and Hawaii (Lounibos 2002, 
Kaufman et al. 2012).  Although the shipping network has been implicated as a means 
for vector dispersal since the 15th century and the unintentional transport of mosquitoes 
through aerial transport was recognized as early as the 1930s, detailed records describing 
vector invasions throughout the world remain sparse.  Subsequently, rates of mosquito 
importation and the pathogens they harbor remain undetermined (Griffitts and Griffitts 
1931, Lounibos 2002).  
The spread of WNV to New York in 1999 and the recent discovery of the 
Australian mosquito, Aedes notoscriptus, in California, August 2014, demonstrates that 
mosquito invasion in the U.S. is frequent (ProMed-mail 2014).  In the last decade, 
chikungunya virus, a forest dwelling virus maintained among Aedes species mosquitoes 
and non-human primates, spread beyond its historical boundaries in Central, East and 
South Africa to the Oceana region reiterating the ability for vector-borne diseases to 
spread through traveling humans (Powers 2014).  In 2007 the virus was imported to Italy 
through an infected human.  In December of 2013, local transmission was recorded in 
the Caribbean, even after preventative measures were taken in Latin America under the 
guidance of the Center for Disease Control and Prevention (CDC) (Omarjee et al. 2014, 
Powers 2014).  Biological invasions are associated with a variety of adverse affects and 
are often irreversible once established (Simberloff 2005).  For this reason, risk 
assessments have been adopted internationally to guide human activities by 
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characterizing the hazard non-native animals pose to ecological systems and evaluating 
how certain practices modify rates of exposure (Simberloff 2005).  
Rift Valley fever virus (RVFV) is an emerging mosquito-borne disease in Africa 
and the Middle East that adversely affects livestock production and human health.  Due 
to its potential effects to both human and animal health RVFV is listed as a select agent 
by the U.S. Department of Health and Human Services and considered a foreign 
arthropod-borne animal disease threat by the U.S. Department of Agriculture (Hartley et 
al. 2011).  Like WNV, RVFV is primarily transmitted through the bite of infected 
mosquitoes and utilizes wild and domestic animals as amplification hosts.  RVFV has 
already spread from Africa to the Arabian Peninsula and is following a similar global 
expansion as WNV, which was first described in Uganda and is now the most widely 
distributed arthropod-borne virus in the world (Bird et al. 2009).  RVFV has been 
isolated from at least 40 mosquito species (Turell et al. 2008b) and can be transmitted by 
at least six different genera (Turell et al. 2002).  Once infected with RVFV, mosquitoes 
can remain infected for more than 30 days in the laboratory (Turell et al. 1985) 
demonstrating an innate ability to import RVFV into the U.S.  Certain species of 
floodwater mosquitoes, like Aedes mcintoshi, are known to maintain RVFV between 
RVFV epidemics by infecting their offspring through a process of transovarial 
transmission (Linthicum et al. 1985).  Subsequently, all life-stages of mosquitoes are 
implicated as potential vehicles of RVFV introduction.  As the frequency of international 
travel and trade rises, the importation of mosquito vectors is likely to increase making 
the spread of RVFV to the U.S. via an infected mosquito a growing threat.  
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Mosquito borne viruses (arboviruses) are largely zoonotic because they depend 
on other animal hosts to maintain the virus in nature while humans are often incidental 
or dead-end hosts (Gubler 2002).  However, the arboviruses that tend to cause the largest 
public health impact are those that produce a viremia in humans (chikungunya, Dengue, 
Yellow fever) (Gubler 2002).  Dengue virus spread around the world in the nineteenth 
century through the expanding shipping network and is unique among arboviruses 
because it does not require an animal reservoir host and is completely adapted to an 
urban transmission cycle among humans (Gubler 2002, Jones et al. 2008).  RVFV is 
mainly associated with domestic and peri-domestic animals such as goats, sheep, and 
cattle, therefore activity mainly occurs in rural regions and not urban centers (Rolin et al. 
2013).  The importation of RVFV infected ruminants to the U.S. is generally assumed to 
be low because trade bans to prevent the spread of foot-and-mouth disease already 
restrict trade from many countries with endemic RVFV (Rolin et al. 2013).  The role 
humans may play as amplification hosts largely has been considered low (Chevalier et 
al. 2010).  However, if humans are not dead end hosts and can produce an infectious 
viremia, their capacity to spread RVFV around the globe is likely high considering the 
ease and frequency of modern international travel (Hartley et al. 2011).   
Although significant progress is being made with the development of animal 
vaccines for RVFV, vaccine programs targeting domestic animals might not be 
sufficient to break the transmission cycle of RVFV in the U.S. if wild animals are 
responsible for maintaining and amplifying the virus (Kakani et al. 2010, Hartley et al. 
2011, Rolin et al. 2013).  Should RVFV arrive, diagnosing the disease and controlling 
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the spread of infected mosquitoes and vertebrates will take time, therefore, proactive 
management plans should be created to minimize the time to react and break 
transmission of the pathogen. Currently the information on high-risk regions for RVFV 
introduction is underdeveloped hindering the ability for vector control to properly 
prepare for an introduction scenario of RVFV as mosquito populations vary 
geographically (Hartley et al. 2011).  The invasion process is often difficult to foresee, as 
it is a complex of demographic, evolutionary, and environmental factors.  Measuring 
propagule pressure, which is directly related to the frequency of invasion, can provide 
important information on how to reduce introduction events by identifying high-risk 
pathways and high-risk regions for introduction (Simberloff 2005, Kilpatrick 2011, 
Hatcher et al. 2012).  
In anticipation of continued pathogen emergence, the development of proactive 
management plans and intervention strategies will be more efficient and effective than 
retrospective plans developed after mosquitoes, and the pathogens they harbor, arrive in 
the U.S.  A number of reviews discuss potential vertebrate hosts, disease vectors, and 
environments potentially conducive to RVFV transmission in the U.S., but none have 
quantitatively identified high-risk regions and routes of RVFV introduction to the U.S. 
(Kasari et al. 2008, Hartley et al. 2011, Barker et al. 2013, Rolin et al. 2013, Golnar et al. 
2014).  Based on the qualitative discussion by Kasari et al. (2008) the most likely 
pathway of RVFV introduction to the U.S. is proposed to be through an infected 
mosquito transported on a plane, similar to the putative pathway of WNV introduction to 
New York in 1999 (Kasari et al. 2008).  Other pathways of RVFV introduction include 
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the importation of RVFV infected animals, entry of RVFV infected people, the transport 
of larvae via tire trade and the smuggling of live virus (Kilpatrick et al. 2006c, Kasari et 
al. 2008, Hartley et al. 2011).  The overall goal of this analysis is to quantitatively 
evaluate routes of RVFV introduction into the U.S. to guide prevention efforts and 
inform control efforts should the virus arrive.  Specific objectives are to quantitatively 
evaluate (a) pathways for RVFV introduction into the U.S., (b) identify high-risk regions 
for RVFV introduction events and (c) identify RVFV endemic regions at risk for 
exporting RVFV to the U.S.   
 
Methods 
To estimate the relative risk of different pathways of RVFV introduction to the 
U.S., the number of infectious mosquitoes arriving in the U.S. for each pathway was 
quantified.  Four pathways were considered: infected mosquitoes arriving by airplane, 
infected mosquitoes arriving by boat, infected humans arriving by flight, and the trade of 
infected mammals (Kilpatrick et al. 2006b, Kilpatrick et al. 2006c, Kasari et al. 2008). 
To calculate the number of infectious mosquito days per year resulting from each 
pathway the (i) number of mosquitoes arriving to the U.S. each year was multiplied by 
the (ii) fraction likely to transmit virus and the (iii) length of infectiousness (Kilpatrick et 
al. 2006b, Kilpatrick et al. 2006c).  Because no data exists to properly quantify the 
number of mosquitoes likely to feed on an infected vertebrate imported to the U.S. the 
rate was estimated as the product of (a) mosquito biting rate, (b) the fraction of 
bloodmeals likely to be from a mammalian host, the (c) vector host ratio, and the (d) 
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duration of mammal infection.  The (a) biting rate of mosquitoes was estimated to be 
once every four days (0.25) (Spielman and d'Antonio 2002).  The (b) fraction of 
bloodmeals likely to be from a mammalian host was estimated to be 0.52 based on data 
aggregated from 39 mosquito-feeding studies across the United States (Golnar et al. 
2014).  The (c) vector-host ratio was assumed to be constant for humans and mammalian 
vertebrates and range between 1 and 4 (Johansson et al. 2012). The (d) duration of 
mammal infection was estimated to be 4 days, even though it can range between 1-7 
days (Golnar et al. 2014).  Based on these estimates, the number of mosquitoes biting 
vertebrates in the U.S. is estimated to be 1.32 per day (Low: 0.52; High: 2.08). 
Estimates for mosquito infection rate, vertebrate infection rate, human infection 
rate, rate of mosquito infestation on planes, rate of mosquito infestation on ships, and 
infectious mosquitoes resulting from feeding on infected vertebrates were estimated 
based on data obtained from published studies located using Web of Science, NCBI’s 
Pubmed, and the Armed Forces Pest Management Board Literature Retrieval System. 
Because data obtained from a variety of published studies across the globe were utilized 
to estimate parameters for this analysis, low and high-risk estimates dictated by the 
available data were utilized to estimate high and low introduction scenarios.  
 
Model assumptions 
 Modeling vector-borne pathogen movement is a complex endeavor in 
comparison to directly transmitted diseases (Tatem 2014).  To simplify this analysis key 
simplifying assumptions were made to explore the frequency of RVFV introduction to 
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the U.S.: (1) RVFV is considered endemic and circulating year-round in all countries 
with recorded RVFV activity as indicated by the Center for Disease Control and 
Prevention (Angola, Botswana, Burkina Faso, Cameroon, Central African Republic, 
Chad, Democratic Republic of the Congo, Egypt, Ethiopia, Gabon, Gambia, Guinea, 
Kenya, Madagascar, Mali, Mauritania, Mozambique, Namibia, Niger, Nigeria, Republic 
of Congo, Saudi Arabia, Senegal, Somalia, South Africa, South Sudan, Sudan, Tanzania, 
Uganda, Yemen, Zambia, Zimbabwe) (CDC 2013), (2) the infection rate is homogenous 
among all mosquito species, (3) humans produce an infectious RVFV viremia 
comparable to other competent mammals, (4) all imported mammals are potentially 
competent RVFV hosts, (5) vertebrate and mosquito infection rates are the same 
spatially and temporally in endemic countries, (6) the numbers of mosquitoes imported 
to the U.S. on ships and airplanes is comparable to studies that quantified infestation 
rates in other regions other than the U.S. (7) once infected, infectious mosquitoes remain 
infectious for the duration of their lifetime and (8) estimates of ship traffic, flight traffic, 
human travel, vertebrate trade, mosquito infestation rate, fraction of bloodmeals likely to 
be from human hosts and the fraction of bloodmeals likely to be from mammalian hosts 
were treated as constants. Based on these simplifying assumptions the relative risk 
different RVFV introduction pathways to the U.S. were quantified.   
 
Host movement data 
 Predicting pandemic threats remains a difficult task, however the relationship 
between human movement and disease epidemics is clear.  Before the global expansion 
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of human populations in the last five centuries disease pandemics were relatively 
confined, but following the increased frequency of international travel pathogen 
importation is a growing phenomena (Kilpatrick et al. 2006b, Jones et al. 2008). 
Subsequently, many attempts have been made to quantify local and international 
movement patterns to understand disease epidemiology.  Studies have utilized Census 
data, border traffic surveys, social media, satellite nightlights, mobile phones, and Air 
and shipping statistics to capture patterns of movement (Tatem 2014).  Although a 
wealth of data exists to understand movement patterns at a fine-scale, most of this 
information remains prohibitively expensive.  However a variety of sources exist to 
quantify the movement of hosts to the U.S. from countries with active RVFV. 
International flight data: The T-100 International Segment (All Carriers) 
Database provided by the Research and Innovation Technology Administration of the 
Bureau of Transportation Statistics contains non-stop segment data that is reported by 
both U.S. and foreign air carriers. Data for 2012 and 2013 downloaded from the online 
database on September 3rd, 2014 (United-Nations 2014).  Data from 2012 and 2013 on 
departures, passengers, origin airport, destination airport, and year was combined to 
estimate the average number of direct flights arriving to the U.S. from countries with 
RVFV activity.  Based on air traffic in 2012 and 2013 obtained from the Transtats 
database, the number of direct flights to the U.S. from areas with RVFV activity is 
estimated to be 3,515 flights per year (Bureau of Transportation Statistics-Transtats). 
Based on passenger data it is estimated that 697,384 humans travel from countries with 
RVFV activity to the U.S. per year.  
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International shipping data: The frequency of ships arriving in the U.S. from 
countries with RVFV activity was estimated based on calculations by Drake and Lodge, 
2004.  Drake and Lodge explored the role of ballast water as a invasion pathway for 
freshwater species by creating a gravity model to estimate the total number of ships 
travelling between each pair of ports yearly. Their analysis utilizes data on 28,748 ship 
arrivals to the U.S. during the year of 2000 obtained from the National Ballast Water 
Information Clearing House (Drake and Lodge 2004).  Based on the supplemental data 
(Appendix A) about 474 ships per year arrive in the U.S. from countries with RVFV 
activity (Drake and Lodge 2004).   
Movement of vertebrates: Data from the United Nations Comtrade Database 
(United-Nations 2014) was obtained to estimate the number of mammals being traded to 
the U.S. and data from the CITES wildlife trade database (UNEP-WCMC 2014) utilized 
to estimate the number of wild animals being imported to the U.S. from countries with 
RVFV activity.  In total, 65 live mammals were imported yearly to the U.S. based on 
commodity codes 0102 (live Animals), 0103 (Live swine), 0104 (live sheep and goats), 
010611 (live primates), 010613 (camels and other camelids), 010614 (rabbits and hares) 
downloaded from the UN Comtrade Database for the years 2010-2013 (United-Nations 
2014). On average 120.5 wild animals were imported to the U.S. based on data from the 
CITES wildlife trade database (UNEP-WCMC 2014).  
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Mosquito importation 
To estimate the average number of mosquitoes transported by airplane, published 
data that recorded the number of airplanes inspected and the numbers of live mosquitoes 
found was aggregated to calculate the average number of mosquitoes that are transported 
alive on each airplane.  Multiple studies have recorded the number of mosquitoes found 
on airplanes since the 1930s with infestation rates ranging from 0.00056 mosquitoes per 
plane to 5.5 mosquitoes per plane (Highton and van Someren 1970, Le Maitre and 
Chadee 1983), however to estimate the rate of inadvertent mosquito transport on planes 
only inspections that utilized pesticides to knock down mosquitoes were considered. 
Results from three studies 0.057 (Hughes 1961), 0.61 (Mendonca and Cerqueiru 1947), 
and 2.2 (Russell et al. 1984) mosquitoes per airplane.  Therefore the rate of mosquitoes 
that are transported alive on each airplane was estimated to be 1.13 (Low: 0.057; High: 
2.2). 
Results from a large-scale study that screened 734 ships arriving from 27 
different countries and six different continents demonstrated that mosquito densities 
varied from 1-346 mosquitoes, however the average number of mosquitoes per ship was 
estimated to be 15.5 adults (Nie et al. 2004).  Mosquito larvae can be transported in a 
variety of open containers, but used tires have been implicated as the introduction 
pathway for Aedes japonicus and Aedes albopictus (Lounibos 2002, Benedict et al. 
2007).  Therefore, the magnitude of tire trade is utilized to estimate the rates of larvae 
importation into the U.S. (Benedict et al. 2007).  In an effort to quantify the risk of Aedes 
albopictus introduction to the U.S. by tire transport, a study by Craven et al. 1988 
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inspected 22,051 tires for mosquito eggs and larva in the U.S. and determined that the 
infestation rate of tires was 0.0006802 (Craven et al. 1988).  Based on statistics from the 
UN Comtrade database (commodity code 401220) the average rate of tires imported into 
the U.S. from RVFV active regions (South Africa, Tanzania, Kenya) was 4525 per year. 
Because the average clutch size for Aedes albopictus eggs is about 80, the proportion of 
pupae that are females is estimated to be 0.5 and the rate of adult emergence is estimated 
to be 0.83 (based on Aedes aegypti life table model) (Armbruster et al. 2002, Focks et al. 
1993) the number of larva transported to the U.S. per year is estimated to be 101.6 
(0.0006802*4525*80*0.5*0.83).  
The fraction of infectious adult mosquitoes capable of transmitting RVFV once 
in the U.S. was determined based on the product of two estimates: the average RVFV 
infection rate of mosquitoes in countries with RVFV and the fraction of mosquitoes 
likely to transmit RVFV after biting a host. Results from six different studies that 
screened for RVFV infection among mosquitoes in Senegal, Mauritania, Saudi Arabia, 
Egypt and Kenya (Linthicum et al. 1985, Zeller et al. 1997, Jupp et al. 2002, Diallo et al. 
2005, Faye et al. 2007, Hanafi et al. 2011, Ba et al. 2012) indicate infection rates can be 
as high as 0.00657 in Mauritania (Faye et al. 2007) and as low as 0.000327 in Egypt 
(Hanafi et al. 2011).  Based on this data, the RVFV infection rate in mosquitoes was 
estimated as the mean 0.00345 (Low: 0.000327; High: 0.00657).  The fraction of 
mosquitoes likely to transmit RVFV by bite was estimated based on the average 
theoretical transmission competence of 26 mosquito species from six different genera 
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exposed to a viremia of 107.5 Plaque Forming Units (0.14; 95% CI: 0.092-0.183) (Golnar 
et al. 2014).  
To estimate the duration of mosquito infectiousness in the U.S. the logic 
employed by Kilpatrick et al. (2006) while quantifying the risk of WNV introduction to 
the Galapagos. Mosquitoes have been shown to live in the lab between 30-60 days and it 
takes at least 7 days for mosquitoes to develop a disseminated RVFV infection, therefore 
the duration of mosquito infectiousness was conservatively estimated to be 10-20 days 
(Turell et al. 1985, Oda et al. 2002, Kilpatrick et al. 2006c).  
The fraction of larva arriving in the U.S. likely to transmit RVFV was calculated 
as the product of three estimates (i) the average RVFV infection rate of mosquitoes in 
countries with RVFV, (ii) the fraction of Adult mosquitoes likely to transmit RVFV after 
biting a host, and (iii) the fraction of eggs likely to become infected via transovarial 
transmission.  The first two parameters are the same as described above. The vertical 
infection rate in mosquitoes was estimated to be the product of mosquito infection rate 
(0.000327-0.00657) and the rate of transovarial transmission observed in populations of 
Aedes mcintoshi (0.0000299) during the inter-epidemic period in Kenya (Lithicum et al. 
1984).  The duration of infectiousness for vertically infected adult mosquitoes was 
estimated to be 10 days longer (20-30 days) than infected mosquitoes transported by 
plane because they emerge as infectious adults.  
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Infected vertebrates 
 Vertebrate hosts need to produce an infectious viremia that can infect mosquitoes 
in order to import RVFV to the U.S. Experimental infection studies have shown that a 
number mammals, including rodents, new world monkeys, camels, and bovine animals 
produce viremia levels sufficient to infect mosquitoes that last between 1-7 days, 
however no reptiles, amphibians, or birds have ever been implicated as potential 
amplification hosts (Golnar et al. 2014).  The classic RVFV transmission paradigm 
implicates peri-domestic livestock as important amplification hosts, however serological 
studies have found RVFV antibodies in a variety of wildlife hosts (Evans et al. 2008).  It 
is more likely that trade in infectious livestock during a RVFV outbreak would result in 
the importation of RVFV to the U.S., but wildlife mammals cannot be ruled out.   
Quarantine measures are established in the U.S., however because the extent of these 
measures is unknown it is assumed that vessel travel time (ship or plane) or any duration 
of quarantine does not affect the magnitude and duration of vertebrate infectiousness in 
the U.S. (Rolin et al. 2013). 
To estimate the number of infectious mosquito days resulting from mammalian 
hosts being transported to the U.S. the fraction of individuals likely to be transported to 
the U.S. (185.5) was multiplied by: (i) the infection rate of mammalian vertebrates 
(0.00137), (ii) duration and magnitude of mammalian infection (0.17), (iii) the fraction 
of mosquitoes likely to transmit RVFV by bite (0.14), (iv) the number of mosquitoes 
feeding on a mammal per day (1.32), (v) and the duration of mosquito infection (15 
days).  The number of mosquitoes feeding on a mammal per day and the fraction of 
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mosquitoes likely to transmit RVFV by bite is the same as estimates used to calculate 
mosquitoes arriving by plane.  Similarly, the duration of mosquito infection is expected 
to be the same as an infectious adult mosquito arriving by plane (10-20 days).  
Antibody prevalence was utilized to estimate the mammalian vertebrate infection 
rate. The prevalence of antibodies against RVFV was estimated based on two studies 
that selected representative groups of sheep, goats, and cattle and screened for IgG and 
IgM antibodies after an epidemic and during the enzootic period allowing the calculation 
of low and high prevalence rates.  The rate of RVFV exposure in mammalian 
populations was estimated by dividing the number of mammals with IgG and IgM 
antibodies by the total number of mammals tested.  IgM has been shown to be detectable 
in cattle for up to two months post exposure (30 days), and IgG is detectable for up to 
five months (150 days) (Morvan et al. 1992).  To estimate the range of infection 
observed among mammalian vertebrates the rate of IgM exposure (0.158) (Zeller et al. 
1995) and IgG exposure (0.0367) (Zeller et al. 1997) were divided by 60 and 150 
respectively.  The mean value between these calculations was estimated to be 0.00137 
(Low: 0.00024; High: 0.0025). 
The duration and magnitude of mammalian host viremia was based on the 
average mammalian competence value (0.17) estimated by Golnar et al. (2014).  The 
vertebrate competence index estimates the relative number of infectious mosquitoes that 
may result from feeding on an infected vertebrate host (Komar et al. 2003) and is 
calculated as the product of susceptibility to infection, mean daily infectiousness to each 
species of mosquito, and duration of infectiousness (Golnar et al. 2014).  
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Infected humans 
To estimate the average number of infectious mosquito days resulting from 
infected humans traveling to the U.S. by plane the number of individuals arriving in the 
U.S. (697,384) was multiplied by (i) the human infection rate (0.00025), (ii) duration 
and magnitude of mammalian infection (0.17), (iii) the fraction of mosquitoes likely to 
transmit RVFV by bite (0.14), (iv) the number of mosquitoes feeding on an mammal per 
day (0.33), (v) and the duration of mosquito infection (10-20 days).  The number of 
mosquitoes feeding on a vertebrate in the U.S. per day (1.32), the fraction of mosquitoes 
likely to transmit RVFV by bite (0.14), and the duration of mosquito infection (10-20 
days) are estimated to be the same as an infectious adult mosquito arriving by plane.  
The average RVFV infection rate in humans was estimated based on the 
prevalence of IgG antibodies in humans and the time IgG remains in the body after 
infection.  Data was obtained from a systematic serosurvey from Senegal during an 
inter-epidemic period from 1991-1993.  Overall, 80 of 3,005 people screened were 
positive with IgG antibodies against RVFV three different regions (Kedougou, Barkedji, 
and Dielmo) and prevalence rates ranged from 0.014 to 0.06. (Zeller et al. 1997).  It is 
well known that antibodies wane over time, with IgM being the initial immunoglobulin 
response, followed by IgG.  A study by Morvan et al. (1992) demonstrated that IgG 
antibodies are detectable 3-5 months after infection in cattle (Morvan et al. 1992).  
Considering IgG exposure may have taken place anytime during a five-month time 
frame (150 days), the IgG prevalence rate in humans (Low: 0.014; High: 0.06) was 
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divided by 150 to calculate the average infection rate: 0.00025 (Low: 0.00009; High: 
0.0004).  
It remains undetermined whether humans contribute to the amplification of 
RVFV during enzootic and epidemic outbreaks.  After the accidental infection of a 
laboratory worker in the 1940s with RVFV blood with a viremia equated to 106.2 LD50 
was isolated, however it was never quantified over time (Smithburn et al. 1949).  The 
presence of a viremia in humans was also demonstrated during the 1977 Egyptian RVFV 
outbreak where humans produced a viremia between 10 4.1-10 8.6 LD50 (Meegan 1979).  
Although it appears humans may produce an infectious viremia insufficient data exists to 
characterize the magnitude and duration of human infectiousness.  Therefore, the 
average mammalian competence value (0.17) calculated by Golner et al. 2014 was 
applied to estimate the duration and magnitude of human infectiousness.  
 
Frequency of invasion in U.S. cities 
 To identify high-risk areas for RVFV introduction in the U.S. the number of 
infectious mosquito days was estimated for each city in the U.S. resulting from flight 
and ship traffic multiplied by parameters described above.  To estimate the number of 
infectious mosquito days arriving at each port the number of flights arriving in each 
region was multiplied by 0.00819, which was calculated as the product of mosquito 
infestation rate, mosquito infection rate, fraction of mosquitoes estimated to transmit 
RVFV by bite, and the number of infectious days.  The number of infectious mosquito 
days resulting from human travel to U.S. cities was estimated by multiplying the number 
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of humans arriving by 0.0000295, which was calculated as a product of human infection 
rate, mammal host infectiousness, number of mosquitoes biting a human per day, 
fraction of mosquitoes estimated to transmit RVFV by bite, and the duration of mosquito 
infection.  To estimate the number infectious mosquito days resulting from ship traffic 
the number of ships arriving was multiplied by 0.0374, which was the sum the risk 
displayed by adult mosquitoes.  Because data from the UN Comtrade Database 
(Vertebrate and tire importation) and CITES Database (Wildlife trade) did not provide 
any resolution regarding the port of arrival or final destination, these pathways were not 
utilized to calculate regional propagule pressure or identify which countries abroad are 
most likely to import RVFV to the U.S.  
 
Results 
Pathways of introduction:  Parameters from published literature are listed in 
Table 2.1.  The relative risk calculated for each pathway is outlined in Table 2.2.  
Humans travelling to the U.S. from regions with RVFV activity represent the highest 
risk of RVFV introduction to the U.S. (Table 2.2).  It is estimated that human travel will 
result in 82.16 (5.28-276) infectious mosquito days per year.  Adult mosquitoes arriving 
by plane and by ship will result in 28.8 (0.06-186) and 25.7 (0.32-128) infectious 
mosquito days per year, respectively. Imported mammals will result in 0.029 (0.0009-
0.14) infectious mosquito days per year.  Vertically infected larvae arriving by ship will 
result in 0.0003 (0.000016-0.0009) infectious mosquito days per year.  
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Pathway Number arriving to U.S. Fraction likely Infection Infectious mosquito 
per year  to transmit by bite duration* days per year
Mosquito by plane (3515)(1.13)a (0.00345)a(0.14)a 15 28.78 (0.06-186)
Mosquito by ship (474)(15.5) (0.00345)a(0.14)a 5 25.72 (0.32-128)
Larvae by tire (4525)(0.0006802)(80)(0.5)(0.83) (0.00345)a(0.0000299)a(0.14)a 25 3.7x10-5
Human travel 697384 (0.00025)a(1.32)(0.17)(0.14) a 15 82.16 (5.28-276)
Mammal Import 185.5 (0.00137)a(1.32)(0.17)(0.14) a 15 0.12 (0-0.56)
Table 2.2 Estimated risk of Rift Valley fever virus introduction to the United States
  aParameter estimates are the middle of the identified range listed in Table 2.1
                      
 
 
Parameter Low High Mean
Number mosquitoes biting vertebrates per day 0.52 2.08 1.32
Mosquitoes infestation rate of planes 0.057 2.2 1.13
Mosquito RVFV infection rate 0.000327 0.00657 0.00345
Transovarial RVFV infection rate 9.78E-09 1.96E-07 0.0000299
Mammal RVFV infection rate 0.00024 0.0024 0.00137
Human RVFV infection rate 9.33E-05 0.0004 0.00025
Mosquito RVFV transmission rate 0.092 0.183 0.14
Mosquito by airplane duration of infection 10 20 15
Mosquito by ship duration of infection 1 10 5
Larvae by tire trade duration of infection 20 30 25
Mosquito infected by vertebrate duration of infection 10 20 15
   See text for references
Table 2.1. Range of parameter estimates based on published literature
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Figure 2.1. Countries in Africa and the Arabian Peninsula implicated to have high-
risk connectivity with the U.S. in the context of RVFV importation.  A gradient 
highlights the risk displayed by each country for importing infectious mosquitoes into 
the U.S. through humans, shipping and air traffic. 
 
 
High-risk ports:  Based on human travel, flight traffic, and shipping, 15 countries 
are implicated as potential importers of RVFV to the U.S. displayed in Figure 2.1 (Saudi 
Arabia, South Africa, Nigeria, Morocco, Egypt, Senegal, Ethiopia, Yemen, Angola, 
Kenya, Mozambique, Zimbabwe, Mali, Niger, and The Gambia).  Movement from Saudi 
Arabia to the U.S. is estimated to result in 24% of all infectious mosquitoes arriving in 
the U.S., followed by South Africa (22%), Nigeria (18%), Senegal (12%), Egypt (11%), 
Ethiopia (9%), Angola (2.0%), Yemen (1%) and Kenya, Mozambique, Zimbabwe, Mali, 
Mali Niger
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Niger, and The Gambia each are estimated to be responsible for less than 1%.  Travel 
from Botswana, Burkina Faso, Cameroon, Central African Republic, Chad, Democratic 
Republic of the Congo, Gabon, Guinea, Madagascar, Mauritania, Namibia, Republic of 
Congo, Somalia, South Sudan, Sudan, Tanzania, Uganda, and Zambia are estimated to 
pose no threat for RVFV introduction.  The import of vertebrates and import of car tires 
are not accounted for in this estimate, but considering the low risk of these pathways 
(Table 2.1), vertebrate imports from the Congo, Botswana, Tanzania and used tire 
imports from Tanzania represent a relatively minimal threat.   
The frequency of RVFV invasion was estimated to be highest in the North East 
region of the U.S. Specifically in New York/New Jersey there was an estimated 26.5 
infectious mosquito days per year (Figure 2.2).  Based on this assessment, Washington 
D.C. (14.5), Houston (11.2), Atlanta (10), and Philadelphia (4) receive the next highest 
frequency of arriving infectious mosquitoes. 
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Figure 2.2. The number of RVFV infectious mosquitoes days in the U.S. per year. 
This value was estimated as a product of (i) the number of mosquitoes arriving to the 
U.S. per year, (ii) the fraction likely to transmit RVFV by bite, and (iii) the duration of 
infection. Data from three pathways were combined: mosquitoes arriving by plane, 
mosquitoes arriving by ship, and the travel of infected humans.  Red indicates infectious 
mosquito days per year resulting from flight traffic and yellow indicates the risk 
infectious mosquito days per year resulting from ship traffic.  
 
 
Discussion  
 The increased emergence of vector-borne diseases over the past 30 years is a 
result of increased vector range and land-use change, but largely due to human 
movement (Jones et al. 2008, Tatem et al. 2012).  The spread of RVFV to the U.S. is 
generally considered low, but concerns remain high due to the significant economic and 
public health impacts associated with the virus (Tatem et al. 2012, Rolin et al. 2013).  
Overall, results from this analysis suggest that human travel is the most important route 
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of RVFV introduction to the U.S. followed by mosquito transport by airplane and 
mosquito transport by ship (Table 2.2).  Results also suggest the importation of 
mammals and the trade of tires are a relatively low risk for RVFV entry into the U.S. 
The role of humans in RVFV amplification and pathogen dispersal remains 
unknown (Smithburn et al. 1949, Meegan 1979, Kasari et al. 2008, Chevalier et al. 2010, 
Hartley et al. 2011, Rolin et al. 2013).  Although RVFV is associated with rural livestock 
communities, international tourists have indeed acquired RVFV, including a French 
Canadian woman and members of the French military (Durand et al. 2001, Rolin et al. 
2013).  As of 2003 arboviruses were one of the most common causes of viral fevers in 
returning tourists, often presenting with non-specific symptoms such as fever and 
myalgia (Spira 2003).  If humans produce a RVFV viremia comparable to other 
mammals this analysis indicates human travel would be a significant route of RVFV 
dispersal to the U.S. (Table 2.2).  The unintentional importation of mosquitoes by 
airplane and ship are also important pathways of RVFV introduction to the U.S. and 
should not be neglected considering the spread of vectors worldwide has spearheaded 
some of the most important epidemics throughout history, including yellow fever, 
typhus, plague, and malaria (Lounibos 2002).  
The small numbers of vertebrates being imported into the U.S. (120.5 per year) is 
responsible for the low risk highlighted by this analysis. RVFV has been spread through 
infected animals, but the time to travel across the Atlantic Ocean combined with 
quarantine measures would likely be longer than the 1-7 day viremic period of most 
mammals (Rolin et al. 2013, Golnar et al. 2014).  Utilizing the magnitude of tire trade 
between the U.S. and RVFV endemic regions as a surrogate to estimate mosquito eggs 
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or larvae present on freighter ships likely results in an underestimate of mosquito 
infestation rates.  However, vertical infection of mosquito eggs in the RVFV system has 
only been demonstrated in one species of mosquito, therefore, the role vertically infected 
larva play in importing RVFV to the U.S. is expected to be negligible in most scenarios.  
The frequency of RVFV introduction to the U.S. is largely concentrated in the 
North East, Central East Coast and Houston, Texas (Figure 1).  Reminiscent of the 1999 
WNV invasion, New York is estimated to receive the highest introduction pressure.  
However should an infectious mosquito arrive in New York, the potential for local 
transmission and establishment remains unknown and further evaluation of local hosts 
and ecological conditions would be important for gauging invasion success.  The use of 
climate matching and remote sensing techniques can be utilized to identify 
environmental conditions supportive of RVFV transmission and the harsh winters of 
New York would likely prevent over-wintering of the virus (Barker et al. 2013).  
Therefore, regions further south with warmer climates year-round may be more 
appropriate for local transmission and establishment.  By calculating the number of 
infectious mosquito days per year that occur regionally in the U.S., Houston, Texas 
receives the fourth most introduction pressure.  This region should be monitored closely 
considering the warm climactic conditions, abundance of cattle, and abundance of the 
highly competent salt marsh mosquito, Aedes sollicitans, which is known to reach 
populations so large that cows die of exsanguination (Abbitt and Abbitt 1981, Gargan et 
al. 1988, Golnar et al. 2014).  
Considering 32 countries have been identified with RVFV activity, only 14 
countries have been identified as likely origins of a RVFV importation into the U.S.  The 
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importation of RVFV to the U.S. is likely to be the highest during an outbreak and 
understanding which countries are most likely to import RVFV to the U.S. is informative 
to surveillance programs and the creation of preventative strategies.  The U.S. is highly 
connected with Saudi Arabia and preventative efforts should be fully activated when 
outbreaks occur in this region.  Overall, authorities responsible for limiting the spread of 
RVFV or other organisms to the U.S. should be particularly concerned with outbreaks in 
Saudi Arabia, South Africa, Nigeria, Egypt, Senegal, Ethiopia, Yemen and Angola 
(Figure 2.1). 
Limitations:  The evaluation of vector-borne pathogen invasion is a complex 
process; therefore this model utilized a number of simplifying assumptions.  Infection 
rates, infestation rates, host/vector abundance levels, competence levels, and movement 
data could be estimated from available studies, however, the addition of local data for 
parameter estimates would improve the resolution of results and help explore 
introduction probabilities at the local scale.  
 
Conclusion 
To quantitatively evaluate routes of RVFV introduction to the U.S. the number of 
infectious mosquitoes arriving in the U.S. per year was estimated for five pathways: 
infected mosquitoes arriving by plane, infected mosquitoes arriving by ship, infected 
mosquito larvae/eggs arriving through tire transport, infected humans travelling to the 
U.S., and the trade of infected mammals.  The movement of infectious humans by flight 
is estimated to be the most significant route of RVFV introduction to the U.S., followed 
by the movement of adult mosquitoes on ships and airplanes. High-risk regions for 
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RVFV introduction were identified to New York, Washington D.C., Atlanta, and 
Houston. Saudi Arabia, South Africa, Nigeria, Egypt, Senegal, Ethiopia, Yemen and 
Angola were identified as countries that pose a risk for importing RVFV to the U.S. 
through movement connectivity.   
Although introduction events are often stochastic and unpredictable, unlikely 
scenarios of disease spread happen, as demonstrated by the spread of WNV to the U.S.  
With the growing frequency of international travel the threat of RVFV introduction will 
only increase.  Key pathways of introduction and high-risk regions within the U.S. 
quantified in this analysis will function as important parameters for comprehensive risk 
models combining environmental data with epidemiological data to evaluate RVFV 
invasion in the U.S.  
In the event that RVFV emerges in the U.S. it will be state and county public 
health departments and the associated vector control agencies that will be critical 
members of the response task force.  Results from this analysis help judge the relative 
risk of RVFV introduction regionally in the U.S. important to mosquito control and 
vaccination strategy development. Should RVFV reach the U.S., clear case definition for 
clinicians and veterinarians will be essential for effective diagnosis and timely response 
efforts.  
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CHAPTER III 
PREDICTING THE MOSQUITO SPECIES AND VERTEBRATE SPECIES 
INVOLVED IN THE THEORETICAL TRANSMISSION OF RIFT VALLEY FEVER 
VIRUS IN THE UNITED STATES* 
 
Introduction 
Rift Valley fever virus (RVFV) is an emerging infectious disease in Africa and 
the Middle East. If introduced to North America, RVFV is capable of serious health and 
socioeconomic consequences potentially incapacitating large numbers of humans, 
decimating susceptible farm animals, and instigating heavy restrictions on livestock 
trade (Weaver and Reisen 2010, Hartley et al. 2011).  Although transmission of the virus 
can occur through aerosol inhalation or direct tissue-tissue contact by handling of 
infected organisms, an enzootic cycle between mosquito vectors and domestic or wild 
animals has been repeatedly proposed as a main mechanism of transmission (Meegan 
and Bailey 1988).  Clinical signs vary by vertebrate species and age, but infected 
pregnant ruminants generally suffer spontaneous abortions and juvenile ruminants suffer 
high mortality while occasional spillover into human populations results in a self-
limiting, febrile illness that may progress to encephalitis, retinitis, blindness, 
hemorrhagic fever or death (Meegan and Bailey 1988, Mandell and Flick 2010, Weaver 
and Reisen 2010, Ikegami and Makino 2011).  In 1931, RVFV was first reported in  
                                                 
*Adapted and reprinted with permission from “Predicting the Mosquito Species and Vertebrate Species 
Involved in the Theoretical Transmission of Rift Valley Fever Virus in the United States” by Golnar, A. J., 
M. J. Turell, A. D. LaBeaud, R. C. Kading, and G. L. Hamer. 2014. PLoS Neglected Tropical Diseases 8: 
e3163. Copyright [2014] by Andrew John Golnar. URL: 
http://www.plosntds.org/article/info%3Adoi%2F10.1371%2Fjournal.pntd.0003163  
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Kenya.  It spread to Egypt in 1977 and was detected on the Arabian Peninsula in 2000 
(Meegan 1979, Fagbo 2002).  Since advancing beyond African borders in 2000, total 
human cases of RVFV include 768 confirmed fatalities, 4,248 confirmed infections and 
over 75,000 suggested unconfirmed cases (CDC 2000a, b, c, WHO 2007a, b, Bouloy and 
Flick 2009, WHO 2010, Hassan et al. 2011).   
The emergence of arthropod-borne viruses (arboviruses) through geographic 
expansion is facilitated when amplification hosts include wild or domestic animals, as 
demonstrated by West Nile virus (WNV), Japanese encephalitis, and epizootic 
hemorrhagic disease (Weaver 2005, Weaver and Reisen 2010).  Aedes and Culex spp. 
mosquitoes are proposed to be the main vectors of RVFV, where Aedes spp. act as the 
reservoir and maintenance vectors that emerge after flood events and feed heavily on 
livestock (Pepin et al. 2010).  Culex spp. mosquitoes then become involved as 
amplifying hosts of RVFV leading to epizootics and the eventual spillover to human 
populations (Bird et al. 2009, Pepin et al. 2010, Ikegami and Makino 2011, Bird and 
Nichol 2012).  However, the understanding of RVFV transmission biology in Africa and 
the Arabian Peninsula remains underdeveloped.  Additionally, unresolved questions 
surround endemic persistence of the virus, such as transovarial transmission (Pepin et al. 
2010).   
Should RVFV arrive, diagnosing the disease and controlling the spread of 
infected vertebrates will take time, and proactive management plans should be created to 
minimize the time to react and break transmission of the pathogen.  Even though RVFV 
is identified as an emerging infectious disease threat and is classified as a “Category A 
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select agent” by both the Centers for Disease Control and Prevention and the US 
Department of Agriculture, gaps in data are preventing a proper evaluation of the 
different roles vectors and vertebrate hosts potentially may play in RVFV transmission 
in the U.S. beyond qualitative conjecture (Hartley et al. 2011, Rolin et al. 2013).  To 
prepare for an arbovirus introduction, it is essential to understand which vectors and 
vertebrate hosts may be responsible for viral amplification and transmission, as disease 
control methods vary depending on the target species (Turell et al. 2008b, Kakani et al. 
2010).  For example, mosquito species using small container habitats for larval 
development are often controlled using larvicides and source reduction of aquatic 
habitat, whereas mosquito species with synchronous emergence following flooding 
events are controlled by adulticides or granular larvicides applied prior to flooding (Rose 
2001, Medlock et al. 2012).  
To assess the role of mosquitoes and hosts in the transmission of a virus, it is 
important to quantify the ability for a mosquito species to transmit a pathogen (vector 
competence), the infectiousness of vertebrate host species (host competence), and 
contact rates between mosquitoes and vertebrate hosts.  In the WNV system, Kilpatrick 
et al. (2005) combined data on vector competence, abundance, and mosquito feeding 
patterns to identify the species of mosquitoes responsible for bridge transmission of 
WNV to humans.  Several studies have then implicated important avian hosts 
disproportionately responsible for WNV amplification based on mosquito host feeding 
patterns, mosquito vector competence data, and vertebrate host competence data (Hamer 
et al. 2009, Hamer et al. 2011).  By applying models utilized in the WNV system, we 
can implicate potentially important vectors and vertebrate hosts in RVFV transmission 
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should the virus arrive.  A number of reviews discuss potential vertebrate hosts, disease 
vectors, and environments that may support RVFV transmission in the U.S., through 
environmental receptivity models (Barker et al. 2013) and spatial overlap of important 
host populations (Kakani et al. 2010).  However, to our knowledge, no study has 
quantitatively evaluated the theoretical importance of different mosquito species and 
vertebrate hosts to RVFV transmission and amplification in the U.S. (Barker et al. 2013). 
This study utilized published and unpublished vector and host competence data 
and mosquito feeding patterns to model the theoretical roles of different mosquito and 
vertebrate species in the amplification and transmission of RVFV in the U.S.  Although 
predictions from this analysis are strictly theoretical, and limited by available data, these 
results highlight critical gaps in knowledge necessary to properly evaluate the potential 
transmission activity of RVFV in the U.S. and provide hypotheses that can support 
proactive arbovirus surveillance and control programs.  
 
Methods 
Vector competence:  Mosquito vector competence studies evaluate the ability of 
mosquitoes to develop an infection and ultimately transmit the pathogen during feeding.  
Data generated from vector competence studies include viral dissemination and 
transmission rates.  Viral dissemination rates are defined as the percentage of orally 
exposed mosquitoes with virus detected in their legs seven or more days after RVFV 
infection.  Transmission rates are defined as the percentage of orally exposed mosquitoes 
(regardless of infection status) that transmitted virus by bite upon refeeding (Turell et al. 
2008b).  Selected studies evaluated mosquito species that occur in the U.S. and 
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monitored dissemination and transmission rates after feeding on a RVFV infected animal 
at the incubation temperature of 26ºC.  RVFV vector competence studies were located 
using Web of Science, NCBI’s Pubmed, and the Armed Forces Pest Management Board 
Literature Retrieval Systems (Gargan et al. 1988, Turell et al. 1988, Turell et al. 1996, 
Turell et al. 2008a, Turell et al. 2008b, Turell et al. 2010, Turell et al. 2013, Turell et al. 
2013). 
Analyzing viral dissemination and transmission data drawn from multiple studies 
is problematic because these data are dependent on the viremic titer of exposure (Turell 
et al. 1988) and the compiled transmission data for this analysis reflects mosquitoes 
exposed to viremia that ranged from 104.3 to 1010.2 plaque-forming units/ml (PFU/ml).  
To address this issue, a regression analysis of log viremia versus experimental 
transmission data from 17 mosquito species (Figure S1, A and B) was utilized to 
estimate the dependence of dissemination and transmission rates on viremic dose.  
Slopes from these regressions were combined with experimental data from each 
mosquito species to interpolate what the dissemination and transmission rates would be 
at the exposure viremia of 107.5 PFU/ml (equations shown in Table S1, Appendix A).  
Mosquito species that demonstrated low overall vector competence in experimental 
transmission studies due to midgut escape barriers or salivary gland barriers (i.e. 
Anopheles crucians (Wiedemann), Cx. nigripalpus (Theobald) and Ae. infirmatus (Dyar 
& Knob)) or had a limited sample size (N<2 mosquitoes) were not used in the regression 
analyses (Turell et al. 2013c).   
The viremia-dissemination equation was equal to 0.098*(Log10 viremia) – 0.268 
and the viremia-transmission rate of a mosquito with a disseminated infection equation 
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was equal to 0.056*(Log10 viremia)-0.0155 (Figure S1, A and B; Table S1, Appendix A).  
Both equations show a positive relationship for dissemination (N= 27; R2= 0.28; p = 
0.0049) and transmission (N= 27; R2= 0.13; p = 0.07) as viremic dose increases.  For 
each mosquito species we generated a linear equation and the y-intercept was adjusted 
based on the difference between the experimentally observed rate and what the 
standardized equations described above (Figure S1, A and B) would predict at a specific 
viremic dose.  This adjusted y-intercept and the standardized slopes from Figure S1, A 
and B (Dissemination m = 0.098, Transmission m = 0.056) were utilized to create two 
unique linear equations for each mosquito species: one to calculate dissemination rate 
and one to calculate transmission rate with respect to viremic dose for each vector 
species.  By solving for y when x= log10 7.5 PFU/ml we were able to estimate 
dissemination and transmission rates at an exposure viremia of 107.5 PFU/ml for each 
mosquito species (Table S1-Appendix A).  When there were multiple data points for a 
mosquito species the averages of exposure viremia and the observed experimental 
transmission data were used to calculate the two linear equations for vector competence 
standardization. 
Additional data points were estimated that describe transmission rates for Ae. 
dorsalis (Meigen), Cx. erythrothorax (Dyar), Cx. tarsalis, and Cx. erraticus (Dyar-
Knab) mosquitoes that developed a disseminated infection based on the estimated 
transmission rates of Turell et al. (Turell et al. 2010). These data were standardized with 
the same methodology described above. Vector competence (Cv) was calculated by 
multiplying the fraction of mosquitoes that develop a disseminated infection after 
feeding on a viremic host by the transmission rate of mosquitoes with disseminated 
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infection based on estimated values for an exposure viremia of 107.5 PFU/ml (Turell et 
al. 2007).  
 
 
             
 
 
 
 
 
 
 
        
 
 
 
 
 
 
Figure 3.1. Dose-dependent relationship between exposure viremia and vector 
competence. The dose-dependent relationship between exposure viremia and 
dissemination rate (A), transmission rate (B), and vector competence (C) displayed by 
17 mosquito species in seven experimental transmission experiments: Ae. aegypti, Ae. 
albopictus, Ae. atlanticus, Ae. canadensis, Ae. cantator, Ae. sollicitans, Ae. 
taeniorhynchus, Ae. triseriatus, Ae. vexans, Cq. perturbans, Cx. erraticus, Cx pipiens, 
Cx. salinarius, Cx. tarsalis, Cx. territans, Ma. dyari, and Ps. ferox.   
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Figure 3.2. A graphical representation of the mean viremia profiles demonstrated 
by 20 different vertebrates after exposure to virulent strains of Rift Valley fever 
virus. Data was compiled from 17 published experimental infection studies and 
unpublished data from Dr. John Morrill and Dr. Michael Turell. Viral titers were 
quantified each day after infection by Plaque Assay or Tissue Culture Infectious Dose 
50, which was converted to PFU/ml by the following equation: PFU/ml = TCID50/ml x 
0.69 (O'Reilly et al. 1994, Mena et al. 2003). When a vertebrate host’s viremia was 
calculated to be negative the daily infectiousness was set to zero as discussed in the 
methodology. References: Bovids: (Davies and Karstad 1981, Morrill et al. 1991, Rippy 
et al. 1992, Nfon et al. 2012); Birds: (Findlay and Daubney 1931) (Turell unpublished 
data); Primate: (Peters et al. 1988, Morrill et al. 1989, Smith et al. 2012) (Morrill 
unpublished data); Rodent: (Swanepoel et al. 1978, Anderson et al. 1987, 1988, Rossi 
and Turell 1988, Anderson et al. 1991b, Anderson et al. 1991a, Pretorius et al. 1997, 
Gora et al. 2000, Geffers et al. 2010, Smith et al. 2010). 
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Vertebrate host competence: When mosquitoes feed on an infected vertebrate a 
fraction of those mosquitoes will become infectious depending on the intensity of the 
vertebrate host’s viremia and the mosquito’s susceptibility to the virus (Kilpatrick et al. 
2007).  Experimental infection studies that exposed vertebrate species to RVFV and 
monitored post-infection viremias were used to create a host competence index (Ci).  
The vertebrate reservoir competence index represents the relative number of infectious 
mosquitoes that may result from feeding on infected vertebrate hosts and is calculated as 
the product of susceptibility to infection, mean daily infectiousness to each species of 
mosquito, and duration of infectiousness (Komar et al. 2003).   Published studies were 
located using Web of Science, NCBI’s Pubmed, and the Armed Forces Pest 
Management Board Literature Retrieval Systems.  Studies utilizing PFU/ml and Tissue 
Culture Infectious Dose 50% (TCID50) techniques to quantify viral titers after 
experimental infection with virulent strains of RVFV (ZH501,T1,T46, AN1830, Kabete, 
80612A, AnD100286, AnD100287, Z8548, FRhL2) were the only inclusion criteria for 
host competence data as no universal conversion between Lethal Dose 50% (LD50) and 
Mouse Lethal Dose 50% (MLD50) was found.  Conversion from TCID50 to PFU/ml was 
obtained by the equation: PFU/ml = TCID50/ml x 0.69 (O'Reilly et al. 1994, Mena et al. 
2003).  
To calculate the vertebrate host competence index for RVFV, an equation 
describing vector competence was calculated utilizing available mosquito transmission 
experiments performed at 26ºC as a linear function of log (host viremia).  This viremia-
vector competence equation (Figure S1, C) describes the fraction of mosquitoes that 
would become infected after feeding on a single viremic host indicating the 
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infectiousness of a vertebrate (Komar et al. 2003, Kilpatrick et al. 2007).  Because of 
limited species-specific experimental transmission data, the viremia-vector competence 
equation is based on the combined experimental transmission data of 17 mosquito 
species (See Figure S1).  Mosquito species that demonstrated low overall vector 
competence in experimental transmission studies due to midgut escape barriers or 
salivary gland barriers or had a limited sample size as described above were not used to 
calculate the viremia-vector competence relationship (Turell et al. 2013).  The viremia-
vector competence equation (vector competence = 0.062 (Log10 viremia) -0.276; 
R2=0.27; N=27; P= <0.001) was used to calculate the daily infectiousness of vertebrate 
hosts by inserting daily vertebrate host viremia titers into the equation.  When the 
equation calculated a vertebrate host’s infectiousness to be negative the vertebrate host’s 
daily infectiousness was set to zero (Kilpatrick et al. 2007).  These daily values were 
summed over the host’s viremic period and used as the vertebrate species’ competence 
index (Ci).  When multiple experimental studies existed for a particular vertebrate 
species or taxonomic group a mean Ci was calculated (Komar et al. 2003, Kilpatrick et 
al. 2007, Perez-Ramirez et al. 2014). 
Vector amplification fraction:  To determine the theoretical importance of a 
mosquito to RVFV transmission it is important to consider contact rates between vectors 
and vertebrate hosts.  The amplification fraction estimates the number of infectious 
mosquitoes resulting from feeding on a particular host and can be utilized as an index to 
compare the relative role of various vectors in transmission.  In the WNV system, the 
relative number of infectious (transmitting) mosquito vectors resulting from feeding on a 
vertebrate host was estimated by Kent et al. (Kent et al. 2009) utilizing the following 
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equation: Fi = Bi2 * Ci where Fi = the relative number of infectious mosquitoes resulting 
from feeding on each vertebrate species i, where Bi = the proportion of blood meals from 
species i and Ci = reservoir competence.  This equation was modified from Kilpatrick et 
al. (Kilpatrick et al. 2006a) which estimated the fraction of WNV-infectious mosquitoes, 
Fi,  resulting from feeding on each avian species, i, as the product of the relative 
abundance, the vertebrate reservoir competence index, Ci, and the mosquito forage ratio.  
Kent et al. (Kent et al. 2009) found that the relative abundance of each avian species 
cancelled out when multiplied by the forage ratio, of which the denominator is relative 
abundance.  Fi as defined by Kilpatrick et al. (Kilpatrick et al. 2006a) was therefore 
reduced to the product of Ci and the proportion of blood meals from species i.  Because 
the viremia-vector competence relationship used in this analysis is based on data from 
multiple mosquito species, Kent et al’s (Kent et al. 2009) Fi equation was modified to 
multiply by the mosquito’s vector competence value (Cv) to account for the differences 
observed in mosquito vector transmission competence across species.  The modified 
equation is referred to as the vector amplification fraction (Fvi) and provides a theoretical 
means to compare the role of various vector species in the transmission of RVFV.  
Fvi = Bi2 * Ci * Cv  
In the Fvi equation, the number of infectious mosquitoes resulting from feeding 
on a vertebrate host, Fvi, is equal to vertebrate host competence (Ci), multiplied by the 
vector competence (Cv), multiplied by the fraction of the total blood meals from host i 
squared (Bi2) (Kent et al. 2009, Hamer et al. 2011).  Bi represents the number of blood 
meals taken from a vertebrate host species divided by the total blood meals taken.  Bi is 
unique to each mosquito species and is used as an indicator of exposure to RVFV and as 
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an indicator of potential RVFV-infectious bites received by a host species, or taxonomic 
group (Muñoz et al. 2012).  Mosquito host feeding data from 39 studies were combined 
to generate a robust estimate of mosquito feeding patterns at the taxonomic resolution of 
Class and Order compiled into Table S2 (See Appendix A).  Vertebrate hosts fed on by 
mosquitoes lacking a competence index (Ci) were assigned the closest taxonomic mean 
(Perez-Ramirez et al. 2014).  Only mosquito species with over 40 recorded blood meals 
to calculate vertebrate host feeding proportions (Bi) were included in this analysis.  
When vector competence data were missing for a given mosquito species, vector 
competence values were substituted based on the taxonomic subgenus average (Aedes- 
Ochlerotatus: 0.15; Culex- Melanoconion: 0.04, Culex: 0.11), genus average (Anopheles: 
<0.01;  Psorophora: 0.18, Mansonia: 0.07) or family average (Culicidae: 0.15).  To 
include Ae. aegypti in this analysis host-feeding patterns were estimated based on 
mosquito feeding patterns in Puerto Rico (Barrera et al. 2012).   
Fvi is unique to each mosquito vector-vertebrate host pair and assumes initial 
seroprevalence, susceptibility and competence values are equal among all adult and 
juvenile vertebrate hosts (Dye and Hasibeder 1986, Woolhouse et al. 1997, Hamer et al. 
2011).  In an attempt to control any effect of the exposure dose of RVFV on the outcome 
of mosquito transmission competency, the Fvi calculation only utilized mosquito 
competence values standardized to an exposure dose of 107.5 PFU/ml as described above. 
To calculate a mosquito species’ vector amplification fraction resulting from feeding on 
all vertebrate hosts, all Fvi values reflecting a vector-vertebrate pair were summed for 
each mosquito species (equations shown in Table S3, Appendix A).  This overall risk for 
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a mosquito species to contribute to RVFV transmission in the U.S. was calculated based 
on a weighted percentage relative to the total Fvi displayed by all mosquitoes.  
Vertebrate host amplification fraction:  To explore the theoretical contribution of 
vertebrates to RVFV amplification and transmission in the U.S., Fvi values unique to 
each vector-vertebrate pair described above were summed across each vertebrate host 
instead of by mosquito vector.  The resulting index expresses the relative number of 
infectious mosquitoes generated by each vertebrate host.  Since species-specific 
competence data was lacking for all vector-vertebrate host contacts, the role of 
vertebrate hosts was explored at the taxonomic resolution of class, order, and family.  By 
summing Fvi values with respect to vertebrate host at different taxonomic levels we were 
able to quantify the theoretical amplification fraction displayed by each vertebrate host 
taxonomic group.  This index was expressed as a weighted average by dividing the 
summed Fvi values for a vertebrate group by the total Fvi value calculated for the 
mammalian order (Table S3, Appendix A).  
 
Results 
Vector competence:  Eight experimental studies were identified that fit the 
inclusion criteria for this analysis (Gargan et al. 1988, Turell et al. 1988, Turell et al. 
1996, Turell et al. 2008b, Turell et al. 2008a, Turell et al. 2010, Turell et al. 2013c).  
Data for 26 mosquito species were adjusted utilizing the viremic dose-dependent 
relationship of dissemination and transmission rates based on 17 species of mosquitoes 
(Figure S1, A and B).  Standardized dissemination and transmission values were 
multiplied together to calculate vector competence (Table 3.1 and S1).  The most 
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competent transmission vectors of RVFV when exposed to 107.5 PFU/ml of viremia are 
estimated to be Coquillettidia perturbans (Walker) (0.38), Ae. japonicus japonicus 
(Theobald) (0.37), Cx. tarsalis (0.33), and Ae. excrucians (0.28).  Some mosquito 
species were estimated to be incompetent for RVFV, such as An. crucians (<0.01), Ae. 
infirmatus (<0.01), and Cx. quinquefasciatus (Say) (<0.01) (Table 3.1).  
 
 
Table 3.1.  Estimated dissemination rate, transmission rate, and vector competence  
for mosquitoes exposed to 7.5 log PFU/ml Rift Valley fever virus. 
  Dissemination Transmission 
Vector 
Competence 
Speciescitation ratea rateb (Cv)c 
Coquillettidia perturbans 29 0.53 0.72 0.38 
Aedes j. japonicus 30 0.74 0.51 0.37 
Culex tarsalis 31, 32 0.38 0.87 0.33 
Aedes excrucians 31 0.28 1 0.28 
Aedes canadensis 31 0.7 0.4 0.28 
Aedes sollicitans 31 0.76 0.34 0.25 
Aedes triseriatus 31 0.75 0.32 0.24 
Psorophora ferox 29 0.55 0.32 0.18 
Culex territans 31 0.39 0.45 0.17 
Aedes atlanticus 29 0.36 0.42 0.15 
Aedes taeniorhynchus 21, 31 0.49 0.27 0.13 
Aedes albopictus 33 0.52 0.25 0.13 
Culex salinarius 31 0.54 0.24 0.13 
Culex pipiens 32, 34, 35 0.13 0.9 0.12 
Aedes vexans 21, 29 0.26 0.41 0.11 
Aedes aegypti 34 0.7 0.11 0.08 
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Table 3.1.  Continued 
  Dissemination Transmission 
Vector 
Competence 
Speciescitation ratea rateb (Cv)c 
Aedes cantator 31 0.71 0.11 0.07 
Mansonia dyari 29 0.17 0.4 0.07 
Culex erythrothorax 32 0.17 0.26 0.04 
Culex erraticus 32 0.15 0.28 0.04 
Culex nigripalpus 21, 29, 32 0.06 0.24 0.01 
Anopheles bradleyi-crucians 31 0.17 0.05 0.01 
Aedes infirmatus 29 0.29 0 <0.01 
Anopheles crucians 29 <0.01 <0.01 <0.01 
Culex quinquefasciatus 32, 34 <0.01 0.14 <0.01 
Aedes dorsalis 30 0.32 <0.01 <0.01 
aAverage rate of mosquitoes, regardless of infection status, containing virus in their 
  legs       
b Average rate of refeeding mosquitoes with a disseminated infection that transmitted 
  virus       
c Average rate of disseminated infection after ingesting RVFV multiplied by    
percentage of mosquitoes with disseminated infection that transmitted virus by bite 
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Figure 3.3. Rift Valley fever virus host competence index values for 20 vertebrate 
hosts based on experimental infection studies characterizing viremia profiles in 
PFU/ml or TCID50. The vertebrate host competence index value depends on the viral 
titer circulating in the blood and the duration of the infectious viremia (Komar et al. 
2003). Each value represents the sum of daily probabilities that an infected vertebrate 
host will transmit RVFV to a biting mosquito. This value was obtained by inserting the 
recorded daily viremia of experimentally infected hosts into the viremia-vector 
competence equation [% infectious = 0.062 (Log10 viremia) - 0.276 (R2 = 0.27; p 
<0.001; N = 27)] (Figure S1, C). When a vertebrate host’s viremia was calculated to be 
negative the daily infectiousness was set to zero. Conversion from TCID50 to PFU/ml 
was obtained by the equation: PFU/ml = TCID50/ml x 0.69 (O'Reilly et al. 1994, Mena et 
al. 2003).  *Denotes a vertebrate species found in the U.S. 
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Host competence:  To estimate vertebrate host competence, published data and 
unpublished data provided by Dr. John Morrill from RVFV experimental infections 
(Figure 1) (Findlay and Daubney 1931, Swanepoel et al. 1978, Davies and Karstad 1981, 
Anderson et al. 1987, 1988, Peters et al. 1988, Rossi and Turell 1988, Morrill et al. 1989, 
Anderson et al. 1991b, Anderson et al. 1991a, Morrill et al. 1991, Rippy et al. 1992, 
O'Reilly et al. 1994, Pretorius et al. 1997, Gora et al. 2000, Mena et al. 2003, Geffers et 
al. 2010, Nfon et al. 2012, Smith et al. 2012) were inserted into a viremia-vector 
competence equation that describes the relative number of infectious mosquitoes 
resulting from feeding on a vertebrate host (Figure S1, C).  Exposure viremia dosages 
ranged from 104.3-10.2 PFU/ml at an incubation temperature of 26ºC.  With this approach, 
12 vertebrate species demonstrated reservoir competence by producing sufficient 
viremia titers to infect mosquitoes after exposure to RVFV, all of which were mammals 
(Figure 2) (O'Reilly et al. 1994, Komar et al. 2003, Mena et al. 2003).  Vertebrate host 
species demonstrating competence for viral amplification were the following: sheep 
(Ovis aries, Class Artiodactyla), domestic cow (Bos taurus, Artiodactyla), domestic goat 
(Capra aegagrus hircus, Artiodactyla), mouse (Mus musculus, Rodentia); brown rat 
(Rattus norvegicus, Rodentia), the common marmoset (Callithrix jacchus, Primates); 
four-striped grass mouse (Rhabdomys pumilio, Rodentia); South African pouched mouse 
(Saccostomus campestris, Rodentia); Rhesus macaque  (Macaca mulatta, Primates); 
Griselda’s striped grass mouse (Lemniscomys griselda, Rodentia); African buffalo 
(Syncerus caffer, Artiodactyla); and namaqua rock rat (Aethomys namaquensis, 
Rodentia).  Many species were considered incompetent because they did not develop a 
sufficient viremia profile to infect mosquito vectors (≤104.7 PFU/ml), such as the red 
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rock rat (Aethomys chrysophilus, Rodentia), african grass rat (Arvicanthis niloticus, 
Rodentia), guniea multimammate mouse (Mastomys erythroleucus, Rodentia), natal 
multimammate mouse (Mastomys natalensis, Rodentia), Mongolian gerbil (Meriones 
unguiculatus, Rodentia), Atlantic canary (Serinus canaria, Passeriformes), domestic 
chickens (Gallus gallus, Galliformes) and the Bushveld gerbil (Taera leucogaster, 
Rodentia).   
The vertebrate host competence index averages based on taxonomy were the 
following:  Class: Mammalian (0.17), Aves (0.00); Order: Primates (0.25), Artiodactyla 
(0.21), Rodentia (0.05); Family: Bovidae (0.21), Muridae (0.05), Cricitidae (0.05); 
Genus: Ovis (0.29), Bos (0.19), Capra (0.15), Rattus (0.04).  
 
 
Table 3.2. Relative risk of mosquitoes contributing to Rift Valley fever enzootic  
transmission in the U.S.  
Mosquito Species  Vector Competence (Cv) a (∑Fvi) b % Risk c 
Aedes japonicus japonicus 0.37 3.10E-02 11.42% 
Aedes thibaulti 0.15 ‡ 2.30E-02 8.80% 
Aedes canadensis 0.28 2.00E-02 7.42% 
Culiseta inornata 0.15 ƒ 1.80E-02 6.75% 
Wyeomyia mitchellii 0.15 ƒ 1.80E-02 6.63% 
Aedes sollicitans 0.25 1.50E-02 5.37% 
Coquillettidia perturbans 0.38 1.50E-02 5.36% 
Aedes sticticus 0.15 ‡ 1.40E-02 5.40% 
Aedes aegypti 0.08 1.30E-02 5.04% 
Aedes nigromaculis 0.15 ‡ 1.20E-02 4.46% 
Aedes cantator 0.07 9.60E-03 3.34% 
Psorophora columbiae 0.18† 8.70E-03 3.25% 
Aedes trivittatus 0.15 ‡ 8.30E-03 3.12% 
Aedes fulvus pallens 0.15 ‡ 8.10E-03 3.04% 
Aedes taeniorhynchus 0.13 7.80E-03 2.92% 
Psorophora discolor 0.18† 7.00E-03 2.64% 
Psorophora ferox 0.18 6.60E-03 2.49% 
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Table 3.2. Continued       
Mosquito Species  Vector Competence (Cv) a (∑Fvi) b % Risk c 
Aedes albopictus 0.13 5.90E-03 2.22% 
Aedes atlanticus 0.15 5.70E-03 2.10% 
Mansonia titillans 0.07 † 4.70E-03 1.78% 
Aedes triseriatus 0.24 4.30E-03 1.57% 
Aedes vexans 0.11 3.30E-03 1.26% 
Culex erythrothorax 0.04 3.10E-03 1.02% 
Culex salinarius  0.13 1.90E-03 0.71% 
Culex cedecei 0.04 ‡ 1.00E-03 0.37% 
Deinocerites cancer 0.15 ƒ 9.90E-04 0.37% 
Culex tarsalis  0.33 5.90E-04 0.22% 
Culex erraticus 0.04 5.30E-04 0.19% 
Culex stigmatosoma 0.11 ‡ 3.70E-04 0.14% 
Culex nigripalpus 0.01 3.30E-04 0.09% 
Culex restuans 0.11 ‡ 2.30E-04 0.09% 
Anopheles crucians <0.01 2.30E-04 0.08% 
Anopheles 
quadrimaculatus 
<0.01 † 2.10E-04 0.08% 
Anopheles punctipennis <0.01 † 2.10E-04 0.08% 
Culex pipiens  0.12 1.70E-04 0.07% 
Culex pilosus 0.04 ‡ 1.20E-04 0.05% 
Culiseta moristans 0.15 ƒ 1.10E-04 0.04% 
Aedes infirmatus 0 8.28E-05 0.03% 
Culex territans 0.17 4.80E-06 0.00% 
Culiseta melanura 0.15 ƒ 3.40E-06 0.00% 
Culex peccator 0.04 ‡ 2.10E-07 0.00% 
Aedes dorsalis 0 0.00E+00 0.00% 
Culex quinquefasciatus 0 0.00E+00 0.00% 
a Estimated Transmission Rate (Cv) (Values from Table 1)  
  
b  (∑Fvi ) for each mosquito species where Fi=Bi
2*Ci * Cv 
    
c  ∑Fvi ÷ total Fvi demonstrated by all mosquitoes 
    
†  Genus average (Anopheles: <0.01; Psorophora: 0.18; Mansonia: 0.07)  
‡ Subgenus average (Aedes- Ochlerotatus: 0.15; Culex: Melanoconion: 0.04, 
Culex: 0.11) 
ƒ  Family average substituted (Culicidae: 0.15)      
 
 
Vector amplification fraction:  Among mosquito species evaluated, the vector 
amplification fraction (∑Fvi) ranged from 0 to 0.018 (Table 3.2).  The resulting index 
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was expressed as a weighted percentage relative to the total amplification fraction 
demonstrated by the 40 mosquito species included in this analysis, which ranged from 
0% to 11.7% (Table 3.2; See Table S3 for calculations, Appendix A).  This index 
estimates the relative probability that a mosquito will feed on an infectious vertebrate 
host, develop a disseminated infection into the salivary glands, and ultimately transmit 
RVFV to a vertebrate host during a subsequent blood-feeding event.   Mosquito species 
with the highest amplification fractions were: Ae. japonicus japonicus (Theobald) 
(11.4%), Ae. thibaulti (Dyar and Knab) (8.8%), Ae. canadensis (Theobald) (7.4%), 
Culiseta inornata (Williston) (6.7%), Wyeomyia mitchellii (Theobald) (6.6%), Ae. 
sollicitans (Walker) (5.4%), Cq. perturbans (5.4%), Ae. sticticus (Meigen) (5.4%), Ae. 
aegypti  (5.0%) and Ae. nigromaculis (Ludlow) (4.4%) (Table 3.2).  
Vertebrate host amplification fraction:  Overall four classes (Mammalia, Aves, 
Amphibia, and Reptilia), eight mammalian orders (Artiodactyla, Carnivora, Chiroptera, 
Didelphimorpha, Lagomorpha, Perissodactyla, Primates, Rodentia), six families 
(Bovidae, Cervidae, Cricitidae, Muridae, Sciuridae, Suidae) and seven genera (Bos, 
Capra, Dama, Homo, Odocoilius, Ovis, Rattus) of vertebrates were evaluated with this 
model.  As indicated by vertebrate competence studies, only mammals are competent 
hosts and are estimated to contribute 100% of theoretical RVFV amplification in the 
U.S.  The order Artiodactyla is estimated to contribute 64.3% of all theoretical 
mammalian RVFV amplification followed by the orders Lagomorpha (16.8%), Primates 
(6.8%), Carnivora (4.4%), Rodentia (0.8%), Perissodactyla (0.4%), Didelphimorpha 
(0.1%), and Chiroptera (0.0%) (Table S3, Appendix A).  Because some blood meal data 
was only specific to the taxonomic resolution of Class there were undefined mammalian 
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hosts that represent 6.3% of the risk, which means all % risk estimates are potentially 
underestimated (Table S3, Appendix A). Similarly, within the Artiodactyla order 10.5% 
risk is undefined, therefore, the family Cervidae accounts for at least 56% of the 
theoretical RVFV amplification contributed to Artiodactyla, while Bovidae contributes 
34%, and Suidae contributes <1% (Table S3, Appendix A).   
 
Discussion 
Vector competence:  Rift Valley fever virus has been isolated from at least 40 
African mosquito species and currently 19 North American species have been shown to 
be competent laboratory vectors of RVFV, several of which are known vectors of 
enzootic viruses of large mammals (e.g., Cx. tarsalis and western equine encephalitis 
virus or Ae. taeniorhynchus (Wiedemann) and Venezuelan equine encephalitis).  These 
data suggest that a suite of mosquito vectors could potentially transmit RVFV should the 
virus reach North America (Turell et al. 2008b).   
Overall, results from previous studies have indicated that vector competence for 
RVFV is variable between mosquito species and among different populations of the 
same mosquito species.  These variations in vector competence within mosquito species 
could be due to differences in development temperatures, phenotype, or parasite 
interactions that facilitate or block viral transmission (Turell 1993, Vaughan and Turell 
1996, Kilpatrick et al. 2005, Turell et al. 2010, Iranpour et al. 2011).  Viral infection, 
dissemination rates, and transmission rates are also dependent on the titer of the viremic 
exposure (Turell et al. 1988).  Because mosquito control methods vary for different 
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mosquito species, future RVFV transmission experiments are necessary to better 
understand variations in vector competence (Turell et al. 2010, Iranpour et al. 2011). 
Vertebrate host competence:  The vertebrate host competence index value 
depends on the viral titer circulating in the blood and the duration of this infectious 
viremia (Komar et al. 2003).  As the classic RVFV transmission paradigm would 
hypothesize, which implicates peri-domestic livestock as important amplification hosts, 
the calculated vertebrate host competence index shows sheep, domestic cow, domestic 
goat, and African buffalo may potentially contribute to RVFV amplification (Figure 3.2) 
(Pepin et al. 2010).  Primates from the new world also demonstrate a high competence 
suggesting humans may play a role in RVFV transmission.  In the 1977 Egyptian 
outbreak of RVFV, Meegan et al. (Meegan 1979) demonstrated that humans produce a 
viremia of 10 4.1-10 8.6 LD50, but how this relates to vertebrate competence values of new 
world monkeys remains unclear.  The vertebrate competence index indicates rodents can 
be competent amplification hosts, but their role in viral amplification may be limited as 
mosquitoes rarely use them as blood meal hosts.  The lack of RVFV competence for 
parakeets, canaries, and pigeons has been described, however our analysis of the class 
Aves was limited to a study evaluating the Atlantic canary (S. canaria) (Findlay and 
Daubney 1931) and an unpublished study by Turell et al. evaluating domestic chickens 
(G. gallus), both of which have a competence index of zero.   
It is apparent that RVFV viremia profiles vary between vertebrate hosts (Figure 
3.1 and Figure 3.2).  These variations emphasize the importance of characterizing RVFV 
viremia profiles of domestic and wild animals present in the U.S., especially since their 
immune systems may be more susceptible to a foreign virus.  Experimental infection 
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studies evaluating vertebrate species from the U.S. with larger sample sizes will manifest 
in more accurate competence values and provide a finer set of data to better implicate 
important vertebrate hosts for RVFV amplification should the pathogen emerge in the 
U.S.   
Vector amplification fraction:  Previous experimental transmission studies 
conclude that Cx. tarsalis and Ae. j. japonicus are the most competent vectors with the 
highest risk to transmit RVFV should it arrive in the U.S.; however, vector competence 
does not directly imply a significant role in disease transmission (Gargan et al. 1988, 
Turell et al. 1988, Turell et al. 2007, Turell et al. 2008b, Turell et al. 2010, Iranpour et al. 
2011, Turell et al. 2013).  The vector amplification fraction provides a means to 
quantitatively compare theoretical risk of various mosquito species based on their 
potential to contribute to RVFV transmission in the U.S.  Vector-host contact rates, as 
dictated by mosquito feeding patterns, is a key component to consider when evaluating 
the risk of a mosquito vector, as illustrated by the Cx. tarsalis mosquioto.  Cx. tarsalis is 
one of the most competent vectors of RVFV in the U.S. (Table 3.1), which feeds mainly 
on avian hosts (Table S2, Appendix A), and therefore, is predicted to have a low 
amplification fraction in comparison to other vectors as seen in Table 2 (0.2% of total 
risk).  Recent transmission experiments by Turell et al. (Turell et al. 2013) suggest that 
Ae. j. japonicus mosquitoes are the most competent vector of RVFV in the U.S. 
(previously Cx. tarsalis).  The vector amplification fraction calculated in this study 
further implicates Ae. j. japonicus as a high risk vector with the potential to contribute to 
RVFV transmission in the U.S. (11.4%, Table 2). This invasive mosquito has a high 
vector competence (0.37, Table 1), feeds heavily on competent hosts (Artiodactyla 80% 
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and Primates 16%, Table S1), and is found in all U.S. states east of the Mississippi river 
except for Florida and Louisiana (Kaufman and Fonseca 2014).  Should RVFV spread to 
the U.S., Ae. j. japonicus populations should be carefully monitored for infection and 
potentially targeted for mosquito control (Turell et al. 2013). 
Ae. sticticus and Cs. inornata both demonstrate varying degrees of transmission 
competency, but vector competence for these two species remains undetermined.  In the 
study by Iranpour (Iranpour et al. 2011), RVFV was detected in the saliva of Ae. 
sticticus after experimental infection and Cs. inornata demonstrated both a high 
infection rate (100%; N=5) and high dissemination rate after exposure to RVFV viremia 
between 107.9 to 109.4 PFU/ml (60%; N=3).  Considering both these species feed heavily 
on the order Artiodactyla (Ae. sticticus 94% and Cs. inornata 80%, Table S2) their role 
in RVFV transmission in the U.S. is uncertain and should be evaluated.  Ae. trivittatus is 
another mammal-biting mosquito estimated to have a moderate role in transmission that 
occurs in large populations in the Eastern U.S. and is lacking experimental data.    
Among the top 10 mosquito species theoretically contributing to RVFV 
transmission in the U.S., only five species (Ae. j. japonicus, Ae. sollicitans, Ae. 
canadensis, Cq. perturbans and Ae. aegypti) have data comprehensive enough for this 
analysis.  This underscores the lack in data necessary to estimate the theoretical role of 
different mosquito vectors in RVFV transmission in the U.S.  Of those ranking as high-
risk for contributing to RVFV enzootic transmission, some are limited in geographic 
range within the U.S. (e.g. Wy. mitchellii) underscoring the importance for including 
spatial and temporal mosquito abundance data while evaluating local regions for RVFV 
transmission potential.  These results indicate a gap in experimental transmission data 
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and requisite further vector competence evaluations to properly evaluate the potential 
risk of mosquitoes contributing to RVFV transmission in the U.S.  Future studies should 
pay particular emphasis on assessing and re-evaluating the regional transmission 
competence and population dynamics of Ae. j. japonicus, Cs. inornata, Ae. sollicitans, 
Ae. sticticus (only 13 individuals have been evaluated) (Kaufman and Fonseca 2014), 
Ae. nigromaculis (all data from one study in 1988) (Gargan et al. 1988), and Ae. 
trivittatus because of their estimated risk and abundance in the Eastern U.S. 
Vertebrate host amplification fraction:  Artiodactyla, Lagomorpha, Primates, and 
Carnivora are estimated to be theoretically involved in RVFV amplification in the U.S., 
while the Mammalian orders Perissodactyla, Didelphimorpha and Chiroptera are not 
(Table S3).  The order Chiroptera may deserve further investigation as a potential 
reservoir host as RVFV has been isolated from several bat genera (Calisher et al. 2006) 
and even though antibodies against RVFV have been detected in horses, the family 
Equidae has demonstrated low viremic titers (Yedloutschnig et al. 1981, Olive et al. 
2012).   
Our results suggest that Artiodactyla contributes 64.3% of the theoretical risk for 
RVFV transmission in the U.S., which supports the currently held paradigm that 
Artiodactyla are the most important vertebrate host for RVFV amplification and 
transmission.  Research and control efforts should place a particular emphasis on the 
families Cervidae and Bovidae as they account for at least 56% and 34% of the total risk 
contributed by the order Artiodactyla, respectively (Table S3).  Based on the 2012 
Census of Agriculture (USDA National Agriculture Statistics Service) there are about 90 
million cattle, 5 million sheep, 3 million goats, and 300,000 captive cervids.  There are 
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an estimated 25 million white-tailed deer (Odocoileus virginianus) in the U.S. (Miller et 
al. 2003).  Throughout the U.S. captive and wild ruminants are widely available and 
heavily utilized by mosquitoes (Table S2) emphasizing their potential role in RVFV 
transmission.  
It is important to note that the role of the order Lagomorpha (17%) may be 
inflated by the vector amplification fraction because their estimated vertebrate 
competence was based on a mammalian average (0.17).   No studies provide evidence 
supporting that Lagomorphs are capable of producing an infectious viremia, but little 
research has evaluated their role in RVFV ecology (Findlay and Daubney 1931).  
Similarly, vertebrate competence of the order Carnivora is lacking.  Studies demonstrate 
susceptibility in cats, dogs, ferrets and serological studies demonstrate antibodies against 
RVFV in lions (Panthera leo) and the polecat (Ictonyx striatus) (Gear et al. 1955, Darsie 
and Ward 2005, Olive et al. 2012, CDC 2014a)[72,75-77].  Experimental evaluation 
within the Order Carnivora should focus on the competence of dogs, cats, and raccoons 
because mosquito host-feeding is mainly associated with these species (Table S2).    
Arbovirus amplification in domestic and peridomestic animals and eventual 
spillover to humans is a well-documented phenomenon.  However the permanent 
establishment of dengue and chikungunya viruses in urban, tropical environments 
demonstrates the ability for arboviruses to subsist through human reservoirs (Weaver 
and Reisen 2010), especially important given the recent emergence of chikungunya in 
the Caribbean in 2013 (CDC 2014a).  The vertebrate amplification fraction estimates 
Primates will contribute about 7% of the theoretical RVFV amplification in the U.S. 
(Table S3).  This estimate is based on the assumption that the human viremia profile is 
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comparable to Rhesus macaques and common marmosets.  Viremia data from new-
world monkeys as a surrogate for human viremia may overstate the role of humans in 
RVFV transmission.  In the 1977 Egyptian outbreak of RVFV, Meegan et al. (Meegan 
1979) demonstrated that indeed humans produce a viremia of 10 4.1-10 8.6 LD50, however 
socio-economic factors in the U.S. may limit mosquito-human contact rates, and dampen 
any role in amplification of RVFV.  As such, the role of humans as vertebrate hosts for 
RVFV amplification remains unknown. 
Hypotheses implicating rodents as important hosts for RVFV amplification 
started when high death rates of Arvicanthis abyssinicus and Rattus rattus coincided 
with sheep deaths caused by RVFV in 1932 (Olive et al. 2012).  Experimental studies 
demonstrate rodents can be competent amplification hosts for RVFV (Figure 1 & 2) 
depending on the viremic dose, age, and species (Olive et al. 2012).  However, results 
from the vertebrate amplification fraction suggest members of the order Rodentia are at 
low risk for contributing to RVFV transmission because of infrequent contact with 
mosquitoes (Table S2).  
Limitations:  Given the gaps in data preventing a complete analysis of the 
amplification fraction potentially produced by all mosquito and vertebrate hosts, we 
made several assumptions that limit the accuracy of these results.  This analysis does not 
account for spatial or temporal variation in mosquito abundance or competence, both of 
which are known to be spatially heterogeneous and influence pathogen transmission 
dynamics (Darsie and Ward 2005, Turell et al. 2010).  Many of the mosquito species and 
vertebrate hosts included in the analysis have no competence data and for these species 
we assigned taxonomic averages.  It is important to note that taxonomic averages are not 
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always appropriate and extrapolations based on taxonomic averages for both vectors and 
vertebrate hosts can lead to spurious results (e.g. disparate RVFV vector competence 
exists for several Culex spp.) (Perez-Ramirez et al. 2014).  By combining data on 39 
studies reporting mosquito host-feeding patterns in different regions and landscapes 
across the U.S, we aim to incorporate a robust measure of vertebrate host utilization.  
However, the mosquito host-feeding patterns for several species are based on a single 
study, and given the importance of host availability (Chaves et al. 2010), a single study 
might not be broadly representative of host feeding patterns.  Despite these limitations, 
the results from this study highlight potentially important mosquito vectors and 
vertebrate hosts of RVFV that should be monitored in the event RVFV emerges in the 
U.S.  Additionally, this study identifies knowledge gaps that can be filled by future 
experimental work on both vectors and vertebrate species.  
Conclusion: World-wide zoonotic disease emergence is an increasing 
phenomenon due to environmental changes, ecological disturbances, and 
globalization(Patz et al. 2000).  The U.S. has already been affected by the emergence of 
WNV, recently identified a new zoonotic disease (Heartland virus) (McMullan et al. 
2012, Savage et al. 2013)[80,81], and is threatened by the spread of chikungunya virus 
to the Caribbean (CDC 2014a).  During the initial epidemics of WNV in the U.S. in 
2002 and 2003, many mosquito control programs did not have a strong focus on Culex 
spp. mosquitoes.  As knowledge of the WNV transmission system increased, vector 
control has improved by targeting Culex species to reduce human exposure events.  The 
delay of Culex spp. vector control might have allowed more human WNV disease and 
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may have contributed to the rapid spread of the virus across the U.S. highlighting the 
importance of a priori response strategies for potential viral threats.  
RVFV is of particular concern in the U.S. because it causes disease in humans 
and economically important animals alike.  Even more, its emergence throughout Africa 
and the Arabian Peninsula make it a conceivable threat for future geographic expansion.  
We combined published data to provide an estimate of each vector and vertebrate 
taxon’s contribution to RVFV amplification in the U.S.  However, major gaps in 
knowledge exist preventing a comprehensive evaluation of potentially important vectors 
and vertebrate hosts to RVFV transmission in the U.S.  Results, combined with 
information on abundance of vectors and vertebrate hosts, can provide guidance for 
proactive management programs and aid parameterization for further modeling efforts 
evaluating environmental receptivity of RVFV in the U.S. (Kakani et al. 2010, Barker et 
al. 2013).  Additionally, the framework of this analysis can also be applied to regions in 
Africa and the Arabian Peninsula with endemic RVFV transmission to help identify 
important vectors and vertebrate hosts for vector control and vaccination programs.  
Future research efforts should focus on: 1) further evaluating the dose-dependent 
nature of RVFV vector competence in geographically widespread mosquitoes quantified 
as high risk: Ae. j. japonicus,  Ae. canadensis, Cs. inornata, Ae. sollicitans, Cq. 
perturbans, Ae. sticticus, Ae. nigromaculis, Ae. cantator and Ae. trivitattus 2) 
characterizing local vector competence in high risk areas for RVFV introduction, and 3) 
evaluating the RVFV viremia profiles of vertebrates in the U.S. with particular emphasis 
on the orders Artiodactyla (Cervidae, Bovidae, Suidae), Lagomorpha, and Carnivora 
(domestic dog, domestic cat, raccoon), respectively.    
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CHAPTER IV 
CONCLUSION 
 
World-wide zoonotic disease emergence is an increasing phenomenon due to 
environmental changes, ecological disturbances, landscape domestication, and 
globalization (Patz et al. 2000).  Although introduction events are often stochastic and 
sometimes unpredictable, scenarios of introduction, no matter how unlikely, will occur 
with more frequency as international connectivity increases.  The U.S. is not immune to 
vector-borne disease import and has already been affected by the emergence of WNV 
and is threatened by the spread of chikungunya virus to the Caribbean (CDC 2014a). 
RVFV is of particular concern in the U.S. because it causes disease in humans and 
economically important animals alike.  Even more, its emergence throughout Africa and 
the Arabian Peninsula make it a conceivable threat for future geographic expansion.   
This thesis aims to improve the prediction and mitigation of RVFV importation 
and transmission in the U.S. by identifying key pathways of RVFV introduction and 
evaluating potentially important vectors and vertebrate hosts to RVFV transmission in 
the U.S..  Results, combined with information on abundance of vectors and vertebrate 
hosts, can provide guidance for local management programs to reduce the risk of RVFV 
introduction. New York, Washington D.C., Atlanta, and Houston are implicated as high-
risk regions for introduction, and future research efforts should evaluate locally abundant 
vectors for RVFV transmission competence and evaluate the host competence of locally 
abundant vertebrate hosts, especially Artiodactyla, Lagomorpha, and Carnivora. With 
fine-scale abundance data and host competence data the intensity of RVFV transmission 
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can be predicted at a local scale.  In the short-term control programs should work with 
port authorities to monitor international traffic for infectious mosquitoes or humans 
arriving from Saudi Arabia, South Africa, Nigeria, Egypt, Senegal, Ethiopia, Yemen and 
Angola, especially during RVFV epidemic periods. 
Should RVFV reach the U.S. via an infected traveler or mosquito, clear case 
definition for clinicians will be essential for the effective diagnosis of RVFV. It will be 
state and county public health departments and the associated vector control agencies 
that will be critical members of the response task force.  Although introduction risk and 
important transmission hosts are only pieces of the larger invasion complex, results from 
this thesis offers regional guidance for control efforts, vaccination strategy, and provides 
parameter estimates for more comprehensive modeling efforts combining environmental 
receptivity and epidemiological factors to evaluate the introduction, establishment, and 
spread of RVFV in the U.S.  
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APPENDIX A 
 
Table S1. To standardize Rift Valley fever virus experimental transmission data two 
equations referenced in row 60 that estimate the viremia dose dependence of 
dissemination rate and transmission rate (see Figure S1-A and Figure S1-B) were 
utilized to interpolate what the dissemination and transmission rates would be at the 
exposure viremia of 107.5 PFU/ml. A species average was calculated (Columns H and K) 
and multiplied together to calculate the vector competence at the same exposure viremia 
(Column L). This table is freely available online through the PLoS NTD website. 
doi: 10.1371/journal.pntd.0003163.s002  
(XLS) 
 
Table S2.  Number and percentage of mosquito blood meals grouped by vertebrate host 
class and selected orders. Data is based on 39 combined mosquito feeding studies across 
the United States. This table is freely available online through the PLoS NTD website. 
doi:10.1371/journal.pntd.0003163.s003 
(DOCX) 
 
Table S3. Vector competence data, vertebrate competence data, and mosquito feeding 
patterns were combined to estimate the Rift Valley fever virus amplification fraction 
displayed by the vectors and vertebrates in the United States.  In the Fvi equation (Fvi = 
Bi
2 * Ci * Cv), the number of infectious mosquitoes resulting from feeding on a 
vertebrate host, Fvi, is equal to vertebrate host competence (Ci: located in row 5), 
multiplied by the vector competence (Cv: located in column C), multiplied by the 
fraction of the total blood meals from host i squared (Bi2: indicated in each cell as a 
number divided by total blood meals in column B).  All Fvi values reflecting a vector-
vertebrate pair were summed for each mosquito species (Column AC) and summed for 
each vertebrate species (Row 49). To present these values as a % risk (Column AD) the 
values of the vector amplification fraction were weighted over the total amplification 
demonstrated by all vectors, then multiplied by 100. To express the vertebrate 
contribution to RVFV amplification as a % risk (Row 50), the amplification values at the 
taxonomic resolution of Family and Order were weighted over the total amplification 
estimated by all mammals (Cell: Y49), then multiplied by 100.  Because some blood 
meal data was only specific to the Mammalian class, 6.3% of the estimated amplification 
fraction is undetermined at the resolution of Order. Therefore, all order % risk estimates 
are minimum estimates. This table is freely available online through the PLoS NTD 
website.  
doi:10.1371/journal.pntd.0003163.s004 
(XLS) 
 
